Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Envista HoldingsMEX:NVST 80 Return-on-Tangible-Asset is 5.87% as of Mar. 2026, which is 47% below its 10-year median of 11.05. GuruFocus rates MEX:NVST with a GF Score™ of 80/100 and a GF Value™ of MXN336.13. The stock has 4 warning signs investors should review. Among 855 Medical Devices & Instruments companies, Envista Holdings ranks better than 57.31% on this metric.
Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Envista Holdings's annualizedNet Income for the quarter that ended in Mar. 2026 was MXN2,791 Mil. Envista Holdings's average total tangible assets for the quarter that ended in Mar. 2026 was MXN47,559 Mil. Therefore, Envista Holdings's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2026 was 5.87%.
The historical rank and industry rank for Envista Holdings's Return-on-Tangible-Asset or its related term are showing as below:
MEX:NVST'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: -46.63 Med: 11.05 Max: 27.2
Current: 2.59
During the past 10 years, Envista Holdings's highest Return-on-Tangible-Asset was 27.20%. The lowest was -46.63%. And the median was 11.05%.
MEX:NVST's Return-on-Tangible-Asset is ranked better than 57.31% of 855
companies
in the Medical Devices & Instruments industry
Industry Median: 0.76
vs MEX:NVST: 2.59
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
Envista Holdings Return-on-Tangible-Asset Related Terms
Envista Holdings Return-on-Tangible-Asset Historical Data
* Premium members only.
The historical data trend for Envista Holdings's Return-on-Tangible-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:NVST vs MMSI, MMED, STVN: Return-on-Tangible-Asset Comparison
For the Medical Instruments & Supplies subindustry, Envista Holdings's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Envista Holdings Return-on-Tangible-Asset vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Envista Holdings's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where Envista Holdings's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Mar. 2026) net income data.
What does a Return-on-Tangible-Asset of 5.87% mean?
Envista Holdings (MEX:NVST) has a Return-on-Tangible-Asset of 5.87% as of Mar. 2026. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Envista Holdings and its competitors. This is 47% below median its historical median of 11.05. According to the industry distribution chart, Envista Holdings ranks #365 out of 855 companies in the Medical Devices & Instruments industry, placing it in the top 42.7%.
Is Envista Holdings' Return-on-Tangible-Asset too high?
Envista Holdings' current Return-on-Tangible-Asset of 5.87% is 47% below median its 10-year median of 11.05. The Medical Devices & Instruments industry median Return-on-Tangible-Asset is 0.76. Envista Holdings' value of 5.87% is 672.4% above this industry median. Based on the distribution chart, Envista Holdings ranks #365 out of 855 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Envista Holdings has a GF Score™ of 80/100, reflecting its overall financial health beyond just this single metric.
How does Envista Holdings' Return-on-Tangible-Asset compare to MMSI and MMED?
According to the Medical Devices & Instruments industry distribution chart, Envista Holdings ranks #365 out of 855 companies for Return-on-Tangible-Asset. This puts Envista Holdings in the upper half of its industry. The industry median Return-on-Tangible-Asset is 0.76. Envista Holdings' value of 5.87% is 672.4% above this benchmark. While the company's 10-year median is 11.05 vs. the industry median of 0.76, Envista Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Medical Devices & Instruments company?
The median Return-on-Tangible-Asset among Medical Devices & Instruments companies is 0.76, based on 855 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Envista Holdings's current Return-on-Tangible-Asset of 5.87% is 672.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Envista Holdings and its competitors. For the Medical Devices & Instruments industry, the median Return-on-Tangible-Asset is 0.76 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Envista Holdings's current Return-on-Tangible-Asset is 5.87%, which is 47% below median its own 10-year median of 11.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Envista Holdings stock overvalued right now?
Envista Holdings (MEX:NVST) has a current Return-on-Tangible-Asset of 5.87%. The stock's GF Value™ is MXN336.13, compared to a current price of MXN370.00 — trading 10.1% above its estimated fair value. The current Return-on-Tangible-Asset is 5.87%, which is 47% below median its 10-year median of 11.05 and 672.4% above the Medical Devices & Instruments industry median of 0.76. Envista Holdings' overall GF Score™ is 80/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For Envista Holdings (MEX:NVST), the current Return-on-Tangible-Asset is 5.87% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Envista Holdings (MEX:NVST) Overvalued in 2026?
Based on GuruFocus' analysis, Envista Holdings stock appears to be overvalued.
The current stock price of MXN370.00 is trading 10.1% above its estimated GF Value™ of MXN336.13.
Key valuation signals for MEX:NVST:
Return-on-Tangible-Asset: 5.87% (47% below median its 10-year median of 11.05)
GF Value™: MXN336.13 vs. price of MXN370.00 (10.1% above fair value)
Industry Position: 672.4% above the Medical Devices & Instruments median (#365 of 855)
No single metric tells the full story. See the MEX:NVST stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Envista Holdings Corp is a dental products company. It develops, manufactures, and markets portfolios of dental consumables, equipment, and services to dental professionals. The company's business consists of two segments; Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment, which derives key revenue, develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics, and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. Geographically, the company generates a majority of its revenue from North America, followed by Western Europe and other developed and emerging markets.
80GF Score
Get the complete analysis for MEX:NVST
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:NVST has been successfully added to your 
